Funding
SparingVision raises €44.5m for retinitis pigmentosa gene therapy
Richard Staines
Funding, ophthalmology, Oxford Biomedica, R&D, Sanofi, SparingVision
0 Comment
Market Access/ News/ News/ News/ Patients/ Top stories
US snaps up first supplies of Regeneron’s COVID-19 antibody
Phil Taylor
BARDA, coronavirus, coronavirus vaccine, Funding, infectious disease, Novavax, Regeneron, US
0 Comment
News/ News/ News/ Oncology/ R&D
Poseida Therapeutics aims for $115m stock market launch to fund CAR-T R&D
Richard Staines
cancer, CAR T, Funding, IPO, multiple myeloma, Poseida Therapeutics, Prostate cancer
0 Comment
NodThera raises $55m in Series B round to trial inflammatory disease drugs
Richard Staines
Biotech, Funding, inflammatory diseases, NodThera, pipeline, R&D
0 Comment
Digital/ News/ News/ News/ R&D
AI drug discovery firm Exscientia gets $60M cash injection
Phil Taylor
artificial intelligence, drug discovery, exscientia, Funding, Novo Holdings
0 Comment
Market Access/ News/ News/ News/ R&D
US government gives Moderna $483m for COVID-19 vaccine
Phil Taylor
coronavirus, coronavirus vaccine, Funding, Moderna, usa
0 Comment
Cancer Research UK cuts research funding as COVID-19 hits income
Richard Staines
cancer, Cancer Research UK, coronavirus, COVID-19, Funding, Oncology, R&D
0 Comment